Haemophilia A: Low dose emicizumab effective, will reduce cost by over 50 pc, says ICMR study
New Delhi, June 24 (IANS) Low dose of emicizumab could be as effective as standard dose against Haemophilia A, according to a study led by the Indian Council of Medical… Continue reading Haemophilia A: Low dose emicizumab effective, will reduce cost by over 50 pc, says ICMR study








